Dr. Hasan Ahmad Hasan Albitar, MD

Dr. Albitar practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Dr. Albitar's NPI, 1316466774, was assigned on September 16, 2017. Dr. Albitar holds Minnesota license 66127.

Dr. Albitar's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Dr. Albitar's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Dr. Albitar is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Health System. Dmand AI also links Dr. Albitar to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albitar practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Albitar's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Albitar is licensed in Minnesota.

CMS data shows 1,178 Medicare services from Dr. Albitar across 15 procedure codes in 2024, for 408 Medicare patients. Medicare paid $119,842 for them.

CMS counts 408 Medicare patients who saw Dr. Albitar in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Albitar's median patient age at 72, with 53% women.

In 2024, Dr. Albitar wrote 374 Medicare Part D claims for 81 patients. 49% of them were for generic drugs. CMS names the drug for 324 of them, across 17 drugs with 11 or more claims each, at $110,921 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Albitar for performance year 2024, reported as part of a group. Dr. Albitar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 26 papers to Dr. Albitar, published from 2017 to 2022. 2020 was the busiest year, with 8. The most frequent topics are Bevacizumab, Anti-Bacterial Agents and Diagnosis, Differential. Dr. Albitar has published most often in Am J Med. Dr. Albitar's most frequent co-authors are Vivek N. Iyer, MD, Hanny Toban Al-Samkari, MD and Hector Cajigas.

Dmand AI links Dr. Albitar to 2 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Chronic Cough, upper airway cough syndrome and Cough. Mayo Clinic sponsors the most, 2.

CMS Open Payments shows 61 general payments to Dr. Albitar from 17 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $224.